Chemotherapy and Survival in Patients with Primary High-Grade Extremity and Trunk Soft Tissue Sarcoma

The use of upfront chemotherapy for primary localized soft tissue sarcoma (STS) of the extremity and trunk is debated. It remains unclear if chemotherapy adds clinical benefit, which patients are likely to benefit, and whether the timing of therapy affects outcomes. We used the National Cancer Datab...

Descripción completa

Detalles Bibliográficos
Autores principales: Graham, Danielle S., van Dams, Ritchell, Jackson, Nicholas J., Onyshchenko, Mykola, Eckardt, Mark A., DiPardo, Benjamin J., Nelson, Scott D., Chmielowski, Bartosz, Shabason, Jacob E., Singh, Arun S., Eilber, Fritz C., Kalbasi, Anusha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564235/
https://www.ncbi.nlm.nih.gov/pubmed/32846908
http://dx.doi.org/10.3390/cancers12092389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564235/
https://www.ncbi.nlm.nih.gov/pubmed/32846908
http://dx.doi.org/10.3390/cancers12092389

Ejemplares similares